{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:16:05Z","timestamp":1770509765769,"version":"3.49.0"},"reference-count":63,"publisher":"Impact Journals, LLC","issue":"57","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,7,24]]},"DOI":"10.18632\/oncotarget.25774","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T15:12:50Z","timestamp":1532445170000},"page":"31045-31065","source":"Crossref","is-referenced-by-count":10,"title":["Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection"],"prefix":"10.18632","volume":"9","author":[{"given":"Andrea","family":"Gonz\u00e1lez-Morales","sequence":"first","affiliation":[{"name":"Clinical Neuroproteomics Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), Irunlarrea, Pamplona, Spain"},{"name":"IDISNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Proteored-ISCIII, Proteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), Irunlarrea, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aintzane","family":"Zabaleta","sequence":"additional","affiliation":[{"name":"IDISNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Oncohematology Area, University Hospital of Navarra, Center for Applied Medical Research, CIBERONC, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Guruceaga","sequence":"additional","affiliation":[{"name":"IDISNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Bioinformatics Unit, Center for Applied Medical Research, University of Navarra, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta M.","family":"Alonso","sequence":"additional","affiliation":[{"name":"IDISNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Program in Solid Tumors and Biomarkers, Foundation for the Applied Medical Research, Pamplona, Spain"},{"name":"Department of Pediatrics, University Hospital of Navarra, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Garc\u00eda-Moure","sequence":"additional","affiliation":[{"name":"IDISNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Program in Solid Tumors and Biomarkers, Foundation for the Applied Medical Research, Pamplona, Spain"},{"name":"Department of Pediatrics, University Hospital of Navarra, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Fern\u00e1ndez-Irigoyen","sequence":"additional","affiliation":[{"name":"Clinical Neuroproteomics Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), Irunlarrea, Pamplona, Spain"},{"name":"IDISNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Proteored-ISCIII, Proteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), Irunlarrea, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Santamar\u00eda","sequence":"additional","affiliation":[{"name":"Clinical Neuroproteomics Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), Irunlarrea, Pamplona, Spain"},{"name":"IDISNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Proteored-ISCIII, Proteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), Irunlarrea, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s00018-017-2483-3","article-title":"On glioblastoma and the search for a cure: where do we stand?","volume":"74","author":"Danhier","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Gijtenbeek","year":"2009","journal-title":"Lancet Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI89587","article-title":"Overcoming therapeutic resistance in glioblastoma: the way forward","volume":"127","author":"Van Meir","year":"2017","journal-title":"J Clin Invest"},{"key":"4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Bell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"5","first-page":"734","article-title":"Immunotherapy approaches in the treatment of malignant brain tumors","volume":"123","author":"Vlahovic","year":"2016","journal-title":"Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.coviro.2015.03.009","article-title":"Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints","volume":"13","author":"Fueyo","year":"2015","journal-title":"Curr Opin Virol"},{"key":"7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect","volume":"19","author":"Kyritsis","year":"2000","journal-title":"Oncogene"},{"key":"8","first-page":"120","article-title":"A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency","volume":"7","author":"Alemany","year":"2001","journal-title":"Clin Cancer Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jnci\/95.9.652","article-title":"Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway","volume":"95","author":"Lang","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/156652309789753356","article-title":"Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas","volume":"9","author":"Fueyo","year":"2009","journal-title":"Curr Gene Ther"},{"key":"11","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/jnci\/djm102","article-title":"Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death","volume":"99","author":"Fueyo","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"12","doi-asserted-by":"crossref","first-page":"e97407","DOI":"10.1371\/journal.pone.0097407","article-title":"Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model","volume":"9","author":"Fueyo","year":"2014","journal-title":"PLoS One"},{"key":"13","article-title":"Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients","author":"Diez-Valle","year":"2017","journal-title":"Neurosurgery"},{"key":"14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1158\/1078-0432.CCR-05-1892","article-title":"Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan","volume":"12","author":"Fueyo","year":"2006","journal-title":"Clin Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"11499","DOI":"10.1158\/0008-5472.CAN-07-5312","article-title":"Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter","volume":"67","author":"Fueyo","year":"2007","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.mt.6300400","article-title":"Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death","volume":"16","author":"Fueyo","year":"2008","journal-title":"Mol Ther"},{"key":"17","article-title":"Phase 1b open-label randomized study of the oncolytic adenovirus DNX-2401 administered with or without interferon gamma for recurrent glioblastoma","volume":"35","author":"Fueyo","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma","volume":"36","author":"Wistuba","year":"2018","journal-title":"J Clin Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jnci\/djj161","article-title":"Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus","volume":"98","author":"Kondo","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4161\/auto.5260","article-title":"Adenovirus\u2019s last trick: you say lysis, we say autophagy","volume":"4","author":"Fueyo","year":"2008","journal-title":"Autophagy"},{"key":"21","doi-asserted-by":"crossref","first-page":"e29467","DOI":"10.1371\/journal.pone.0029467","article-title":"The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells","volume":"6","author":"Fueyo","year":"2011","journal-title":"PLoS One"},{"key":"22","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.02032-10","article-title":"Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity","volume":"85","author":"Fueyo","year":"2011","journal-title":"J Virol"},{"key":"23","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1038\/onc.2014.452","article-title":"C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy","volume":"34","author":"Fueyo","year":"2015","journal-title":"Oncogene"},{"key":"24","first-page":"399","article-title":"Nuclear perturbations following adenovirus infection","volume":"272","author":"Matthews","year":"2003","journal-title":"Curr Top Microbiol Immunol"},{"key":"25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1074\/mcp.M900338-MCP200","article-title":"Proteomics analysis of the nucleolus in adenovirus-infected cells","volume":"9","author":"Matthews","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"26","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1128\/JVI.00033-16","article-title":"Morphological, Biochemical, and Functional Study of Viral Replication Compartments Isolated from Adenovirus-Infected Cells","volume":"90","author":"Gonzalez","year":"2016","journal-title":"J Virol"},{"key":"27","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/sj.emboj.7600597","article-title":"Adenoviral proteins mimic nutrient\/growth signals to activate the mTOR pathway for viral replication","volume":"24","author":"Stokoe","year":"2005","journal-title":"EMBO J"},{"key":"28","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/nmeth.2227","article-title":"De novo derivation of proteomes from transcriptomes for transcript and protein identification","volume":"9","author":"Matthews","year":"2012","journal-title":"Nat Methods"},{"key":"29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2017.01.004","article-title":"The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment","volume":"451","author":"Nam","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"30","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.onc.1210031","article-title":"A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells bothand","volume":"26","author":"Kondo","year":"2007","journal-title":"Oncogene"},{"key":"31","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/carcin\/bgp249","article-title":"A novel oncolytic adenovirus selectively silences the expression of tumor-associated STAT3 and exhibits potent antitumoral activity","volume":"30","author":"Wang","year":"2009","journal-title":"Carcinogenesis"},{"key":"32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/hum.2011.101","article-title":"A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer","volume":"23","author":"Wang","year":"2012","journal-title":"Hum Gene Ther"},{"key":"33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.18632\/oncotarget.322","article-title":"The NFkappaB pathway: a therapeutic target in glioblastoma","volume":"2","author":"Fernandez-Luna","year":"2011","journal-title":"Oncotarget"},{"key":"34","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/sj.gt.3301533","article-title":"Activation of NF-kB mediates ICAM-1 induction in respiratory cells exposed to an adenovirus-derived vector","volume":"8","author":"Cabrini","year":"2001","journal-title":"Gene Ther"},{"key":"35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0042-6822(02)00078-8","article-title":"MAP kinases and NF-kappaB collaborate to induce ICAM-1 gene expression in the early phase of adenovirus infection","volume":"307","author":"Cabrini","year":"2003","journal-title":"Virology"},{"key":"36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.gt.3300576","article-title":"High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells","volume":"5","author":"Weissberg","year":"1998","journal-title":"Gene Ther"},{"key":"37","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.gt.3302510","article-title":"Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy","volume":"12","author":"Young","year":"2005","journal-title":"Gene Ther"},{"key":"38","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1089\/hum.2016.143","article-title":"Functional Screening Identifies Human miRNAs that Modulate Adenovirus Propagation in Prostate Cancer Cells","volume":"28","author":"van Beusechem","year":"2017","journal-title":"Hum Gene Ther"},{"key":"39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/hum.2006.126","article-title":"Modification of the Rb-binding domain of replication-competent adenoviral vector enhances cytotoxicity against human esophageal cancers via NF-kappaB activity","volume":"18","author":"Nagata","year":"2007","journal-title":"Hum Gene Ther"},{"key":"40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","article-title":"Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation","volume":"30","author":"Chariot","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"41","doi-asserted-by":"crossref","first-page":"E2875","DOI":"10.1073\/pnas.1203659109","article-title":"Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation","volume":"109","author":"Vardimon","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","article-title":"Signal transduction by the JNK group of MAP kinases","volume":"103","author":"Davis","year":"2000","journal-title":"Cell"},{"key":"43","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/JVI.76.4.1559-1568.2002","article-title":"Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10","volume":"76","author":"Muruve","year":"2002","journal-title":"J Virol"},{"key":"44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jnr.23687","article-title":"Implications of mitogen-activated protein kinase signaling in glioma","volume":"94","author":"Babu","year":"2016","journal-title":"J Neurosci Res"},{"key":"45","first-page":"119","article-title":"Rho\/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation","volume":"29","author":"Jhanwar-Uniyal","year":"2009","journal-title":"Anticancer Res"},{"key":"46","doi-asserted-by":"crossref","first-page":"9956","DOI":"10.1038\/srep09956","article-title":"Combined inhibition of AKT\/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells","volume":"5","author":"Martini","year":"2015","journal-title":"Sci Rep"},{"key":"47","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/stem.521","article-title":"Crosstalk between the PI3K\/mTOR and MEK\/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells","volume":"28","author":"Kitanaka","year":"2010","journal-title":"Stem Cells"},{"key":"48","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/1535-7163.MCT-06-0711","article-title":"MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival","volume":"6","author":"Berens","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"49","first-page":"1135","article-title":"Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion andinvasion","volume":"58","author":"Boyd","year":"1998","journal-title":"Cancer Res"},{"key":"50","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00262-013-1484-9","article-title":"CD137 stimulation and p38 MAPK inhibition improve reactivity in anmodel of glioblastoma immunotherapy","volume":"62","author":"Kramm","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"51","article-title":"Protein kinase C Signaling in Adenoviral Infection","author":"Rajaiya","year":"2016","journal-title":"Biochemistry"},{"key":"52","first-page":"237","article-title":"Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples","volume":"15","author":"Sharif","year":"1999","journal-title":"Int J Oncol"},{"key":"53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1634\/theoncologist.7-1-17","article-title":"Targeting protein kinase C. new therapeutic opportunities against high-grade malignant gliomas?","volume":"7","author":"Schwartsmann","year":"2002","journal-title":"Oncologist"},{"key":"54","doi-asserted-by":"crossref","first-page":"e97495","DOI":"10.1371\/journal.pone.0097495","article-title":"Thetherapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunity","volume":"9","author":"Lamfers","year":"2014","journal-title":"PLoS One"},{"key":"55","doi-asserted-by":"crossref","first-page":"e947872","DOI":"10.4161\/21624011.2014.947872","article-title":"Healing after death: antitumor immunity induced by oncolytic adenoviral therapy","volume":"3","author":"Fueyo","year":"2014","journal-title":"Oncoimmunology"},{"key":"56","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1128\/JVI.74.9.3941-3947.2000","article-title":"Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB","volume":"74","author":"Muruve","year":"2000","journal-title":"J Virol"},{"key":"57","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1158\/0008-5472.CAN-17-0468","article-title":"Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination","volume":"77","author":"Fueyo","year":"2017","journal-title":"Cancer Res"},{"key":"58","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/nprot.2010.123","article-title":"Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS\/MS","volume":"5","author":"Whetton","year":"2010","journal-title":"Nat Protoc"},{"key":"59","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","article-title":"In-gel digestion for mass spectrometric characterization of proteins and proteomes","volume":"1","author":"Mann","year":"2006","journal-title":"Nat Protoc"},{"key":"60","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1074\/mcp.T600050-MCP200","article-title":"The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra","volume":"6","author":"Schaeffer","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"61","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/pr070492f","article-title":"Nonlinear fitting method for determining local false discovery rates from decoy database searches","volume":"7","author":"Seymour","year":"2008","journal-title":"J Proteome Res"},{"key":"62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Eisenacher","year":"2014","journal-title":"Nat Biotechnol"},{"key":"63","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Cox","year":"2016","journal-title":"Nat Methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T19:05:33Z","timestamp":1589051133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":63,"journal-issue":{"issue":"57","published-print":{"date-parts":[[2018,7,24]]}},"alternative-id":["25774","30123426"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25774","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]}}}